Syncom Formulations (India) Limited (SYNCOMF) Share Price & AI Investment Analysis

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus br. Track Syncom Formulations (India) Limited's live NSE:SYNCOMF share price ₹20.03 (+0.10%), market cap ₹₹19B, P/E 22.8. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for SYNCOMF — real-time NSE India stock intelligence.